Published in J Virol on July 01, 2006
NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol (2008) 1.60
How ubiquitin functions with ESCRTs. Traffic (2011) 1.51
Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci U S A (2007) 1.51
The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol (2010) 1.42
Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol (2008) 1.41
Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding. J Virol (2010) 1.27
Antiviral activity of innate immune protein ISG15. J Innate Immun (2009) 1.25
The ESCRT-associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif. J Virol (2010) 1.14
Functional replacement of a retroviral late domain by ubiquitin fusion. Traffic (2008) 1.14
Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. PLoS Pathog (2010) 1.10
Late domain-independent rescue of a release-deficient Moloney murine leukemia virus by the ubiquitin ligase itch. J Virol (2009) 1.00
Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. J Biol Chem (2008) 0.99
Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding. Retrovirology (2013) 0.98
The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1. J Virol (2007) 0.96
Subviral particle release determinants of prototype foamy virus. J Virol (2008) 0.95
The Mechanism of Budding of Retroviruses From Cell Membranes. Adv Virol (2009) 0.94
Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J Virol (2007) 0.93
Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress. J Cell Physiol (2009) 0.92
Viral takeover of the host ubiquitin system. Front Microbiol (2011) 0.90
The role of ITCH protein in human T-cell leukemia virus type 1 release. J Biol Chem (2011) 0.84
Role of ubiquitin in parainfluenza virus 5 particle formation. J Virol (2012) 0.78
Glutamic Acid Residues in HIV-1 p6 Regulate Virus Budding and Membrane Association of Gag. Viruses (2016) 0.76
PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription. Sci Rep (2017) 0.75
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
Protein modification by SUMO. Annu Rev Biochem (2004) 10.59
HIV-1 gag proteins: diverse functions in the virus life cycle. Virology (1998) 7.32
Retrovirus budding. Annu Rev Cell Dev Biol (2004) 7.16
Ubiquitin-binding domains. Nat Rev Mol Cell Biol (2005) 6.77
Viral late domains. J Virol (2002) 4.51
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci U S A (2000) 4.31
A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci U S A (2000) 4.19
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol (1998) 3.84
Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci U S A (2000) 3.83
Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04
HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J Cell Biol (2004) 2.34
Ubiquitination of HIV-1 and MuLV Gag. Virology (2000) 2.33
Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J Virol (2004) 2.24
The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol (2003) 2.19
Ubiquitin in avian leukosis virus particles. Virology (1990) 2.13
Context-dependent effects of L domains and ubiquitination on viral budding. J Virol (2004) 1.92
Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J Virol (2002) 1.67
Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. J Virol (2002) 1.61
Late domain-dependent inhibition of equine infectious anemia virus budding. J Virol (2004) 1.57
Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines. J Biol Chem (1994) 1.49
Retroviruses have differing requirements for proteasome function in the budding process. J Virol (2003) 1.34
Lysines close to the Rous sarcoma virus late domain critical for budding. J Virol (2004) 1.16
Analysis of human immunodeficiency virus type 1 Gag ubiquitination. J Virol (2005) 1.15
Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol (2005) 1.11
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol (2008) 9.37
The protein network of HIV budding. Cell (2003) 7.82
The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol (2004) 4.91
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe (2009) 4.36
Structural organization of authentic, mature HIV-1 virions and cores. EMBO J (2003) 4.32
The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A (2006) 4.15
HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med (2012) 3.17
The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor. Nat Struct Mol Biol (2005) 3.07
Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat Cell Biol (2003) 2.99
SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors. Nat Cell Biol (2011) 2.92
Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell (2011) 2.56
HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog (2007) 2.44
The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure (2006) 2.32
Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J Virol (2004) 2.24
A peptide inhibitor of HIV-1 assembly in vitro. Nat Struct Mol Biol (2005) 2.21
The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol (2003) 2.19
Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol (2005) 2.12
RanGTP mediates nuclear pore complex assembly. Nature (2003) 2.08
Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss. PLoS Pathog (2009) 2.06
Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog (2012) 2.04
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 2.03
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. PLoS Med (2007) 1.99
Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component. Nat Cell Biol (2011) 1.96
The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. J Biol Chem (2004) 1.92
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe (2008) 1.91
Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1. PLoS Biol (2012) 1.79
Dynamics of HIV-1 assembly and release. PLoS Pathog (2009) 1.67
CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J Virol (2010) 1.63
Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein. J Biol Chem (2008) 1.61
NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol (2008) 1.60
Aptamer displacement identifies alternative small-molecule target sites that escape viral resistance. Chem Biol (2007) 1.52
Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. Science (2012) 1.50
Double-labelled HIV-1 particles for study of virus-cell interaction. Virology (2006) 1.49
HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J Biol Chem (2009) 1.47
The molecular architecture of HIV. J Mol Biol (2011) 1.44
Ultrastructural analysis of ESCRT proteins suggests a role for endosome-associated tubular-vesicular membranes in ESCRT function. Traffic (2006) 1.39
Cryo electron tomography of native HIV-1 budding sites. PLoS Pathog (2010) 1.39
Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology (2006) 1.36
Structural analysis of HIV-1 maturation using cryo-electron tomography. PLoS Pathog (2010) 1.36
Fusion between phagosomes, early and late endosomes: a role for actin in fusion between late, but not early endocytic organelles. Mol Biol Cell (2003) 1.36
More than one door - Budding of enveloped viruses through cellular membranes. FEBS Lett (2007) 1.35
Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol (2006) 1.34
Interactions of human retroviruses with the host cell cytoskeleton. Curr Opin Microbiol (2006) 1.26
Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. PLoS Pathog (2013) 1.25
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. Nucleic Acids Res (2013) 1.20
Analysis of human immunodeficiency virus type 1 Gag ubiquitination. J Virol (2005) 1.15
T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells. Virology (2005) 1.11
From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease. Proc Natl Acad Sci U S A (2005) 1.11
Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A. Virology (2002) 1.11
Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines. Cell Microbiol (2013) 1.11
Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J Virol (2010) 1.09
Role of lipids in virus replication. Cold Spring Harb Perspect Biol (2011) 1.08
Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology (2007) 1.08
Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. J Biol Chem (2009) 1.07
The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles. J Virol (2002) 1.04
Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing. FEBS Lett (2004) 1.03
GPS-Prot: a web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinformatics (2011) 1.03
Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G. PLoS Pathog (2012) 1.02
A rapid method for assessing the distribution of gold labeling on thin sections. J Histochem Cytochem (2004) 1.02
Single-molecule coordinate-based analysis of the morphology of HIV-1 assembly sites with near-molecular spatial resolution. Histochem Cell Biol (2012) 1.02
Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end. Nucleic Acids Res (2005) 1.02
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol (2010) 1.01
Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany. J Clin Microbiol (2012) 1.00
Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses (2002) 1.00
Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J Virol (2011) 1.00
Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy. Retrovirology (2009) 0.97
From experimental setup to bioinformatics: an RNAi screening platform to identify host factors involved in HIV-1 replication. Biotechnol J (2010) 0.96
Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. J Med Chem (2009) 0.96
HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi network-associated Lck signaling. Blood (2011) 0.95
HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso. J Acquir Immune Defic Syndr (2008) 0.95
Construction and characterisation of a full-length infectious molecular clone from a fast replicating, X4-tropic HIV-1 CRF02.AG primary isolate. Virology (2003) 0.95
Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression. Retrovirology (2007) 0.94
A quantitative measure for alterations in the actin cytoskeleton investigated with automated high-throughput microscopy. Cytometry A (2010) 0.94
Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease. Antimicrob Agents Chemother (2012) 0.93
Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives. Virology (2004) 0.93
Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J Virol (2007) 0.93
Role of the SP2 domain and its proteolytic cleavage in HIV-1 structural maturation and infectivity. J Virol (2012) 0.92
HIV-1-cellular interactions analyzed by single virus tracing. Eur Biophys J (2008) 0.92
Heritable yeast prions have a highly organized three-dimensional architecture with interfiber structures. Proc Natl Acad Sci U S A (2012) 0.91
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. Retrovirology (2010) 0.90
Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso. J Med Virol (2009) 0.89
Gag-Pol processing during HIV-1 virion maturation: a systems biology approach. PLoS Comput Biol (2013) 0.89
Direct and dynamic detection of HIV-1 in living cells. PLoS One (2012) 0.89
Nuclear RNAs confined to a reticular compartment between chromosome territories. Exp Cell Res (2005) 0.89
Transport of the intracisternal A-type particle Gag polyprotein to the endoplasmic reticulum is mediated by the signal recognition particle. J Virol (2003) 0.87
Comprehensive mutational analysis reveals p6Gag phosphorylation to be dispensable for HIV-1 morphogenesis and replication. J Virol (2012) 0.87
Multimerizable HIV Gag derivative binds to the liquid-disordered phase in model membranes. Cell Microbiol (2012) 0.87
A simpler way of comparing the labelling densities of cellular compartments illustrated using data from VPARP and LAMP-1 immunogold labelling experiments. Histochem Cell Biol (2003) 0.86
Moloney leukemia virus type 10 inhibits reverse transcription and retrotransposition of intracisternal a particles. J Virol (2012) 0.84
The cellular protein lyric interacts with HIV-1 Gag. J Virol (2011) 0.84
Computational identification of novel amino-acid interactions in HIV Gag via correlated evolution. PLoS One (2012) 0.83